Daily Archives: June 19, 2017

Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor

Posted on June 19, 2017 by Gastroenterology Journal

Intestinal fibrosis resulting in (sub)obstruction is a common complication of Crohn’s disease (CD). Rho kinases (ROCKs) play multiple roles in TGFβ-induced myofibroblast activation that could be therapeutic targets. Because systemic ROCK inhibition … Continue reading →

Posted in News | Comments Off on Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct Acting Antiviral Agents

Posted on June 19, 2017 by Gastroenterology Journal

The risk of hepatocellular cancer (HCC) after sustained virological response (SVR) with direct acting antivirals (DAA) is unclear. Our aim was to examine the risk and determinants of HCC in patients cured with DAA. Continue reading →

Posted in News | Comments Off on Risk of Hepatocellular Cancer in HCV Patients Treated With Direct Acting Antiviral Agents

Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents

Posted on June 19, 2017 by Gastroenterology Journal

The risk of hepatocellular cancer (HCC) after sustained virological response (SVR) with direct acting antivirals (DAA) is unclear. Our aim was to examine the risk and determinants of HCC in patients cured with DAA. Continue reading →

Posted in News | Comments Off on Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents

Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor

Posted on June 19, 2017 by Gastroenterology Journal

Intestinal fibrosis resulting in (sub)obstruction is a common complication of Crohn’s disease (CD). Rho kinases (ROCKs) play multiple roles in TGFβ1-induced myofibroblast activation that could be therapeutic targets. Because systemic ROCK inhibition… Continue reading →

Posted in News | Comments Off on Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor